Page last updated: 2024-09-04

10-propargyl-10-deazaaminopterin and probenecid

10-propargyl-10-deazaaminopterin has been researched along with probenecid in 2 studies

Compound Research Comparison

Studies
(10-propargyl-10-deazaaminopterin)
Trials
(10-propargyl-10-deazaaminopterin)
Recent Studies (post-2010)
(10-propargyl-10-deazaaminopterin)
Studies
(probenecid)
Trials
(probenecid)
Recent Studies (post-2010) (probenecid)
11921853,664292375

Protein Interaction Comparison

ProteinTaxonomy10-propargyl-10-deazaaminopterin (IC50)probenecid (IC50)
Solute carrier family 22 member 8Mus musculus (house mouse)3.02
Solute carrier family 22 member 6Homo sapiens (human)6.85
Solute carrier family 22 member 8Homo sapiens (human)6.965
Solute carrier family 22 member 8Rattus norvegicus (Norway rat)6.03

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Azzoli, CG; Fury, MG; Kemeny, N; Kris, MG; Krug, LM; Rizvi, NA; Sharma, S; Wu, N1

Reviews

1 review(s) available for 10-propargyl-10-deazaaminopterin and probenecid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for 10-propargyl-10-deazaaminopterin and probenecid

ArticleYear
A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors.
    Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Probenecid; Treatment Outcome

2006